Genetic research advances new therapies for rare diseases

Researchers are developing new therapeutic strategies to treat various genetic disorders using gene therapy and RNA technology.

In an international study involving the Neuromed Irccs in Italy, scientists demonstrated that a gene therapy approach can correct alterations caused by GNAO1 gene mutations in experimental models. This mutation causes rare encephalopathies in children, leading to movement disorders and seizures. The method uses a viral vector to deliver a functional copy of the gene to cells, aiming to restore protein production and stabilize neural circuits.

Separately, researchers at the University of Toronto have developed an RNA-based therapy designed to combat nonsense mutations. This technique utilizes chemically modified suppressor transfer RNA (sup-tRNA) molecules delivered via lipid nanoparticles. The goal is to allow cells to bypass premature stop signals in messenger RNA, enabling the synthesis of complete, functional proteins. This approach shows promise for treating conditions such as cystic fibrosis and certain forms of muscular dystrophy.